INKT vs MIRA
Comparison between MiNK Therapeutics Inc (INKT, Company) and Mira Pharmaceuticals Inc (MIRA, Company).
Both INKT and MIRA are from the Healthcare sector.
INKT vs MIRA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
INKT
$49M
MIRA
$49M
Max Drawdown
INKT
97.69%
Winner
MIRA
92.69%
Sharpe Ratio
Winner
INKT
0.84
MIRA
-0.09
5Y Beta
Winner
INKT
-0.03
MIRA
1.77
Industry
INKT
Biotechnology
MIRA
Drug Manufacturers - General
P/E Ratio
INKT
-3.41
Winner
MIRA
-4.02
Debt to Equity
INKT
0.00%
MIRA
0.00%
Free Cash Flow Yield
INKT
-12.93%
Winner
MIRA
-8.72%
P/B Ratio
INKT
11.33
Winner
MIRA
4.90
INKT vs MIRA - Historical Returns
Returns include dividend reinvestment.
1M
Winner
INKT
+2.86%
MIRA
-1.96%
3M
Winner
INKT
+8.40%
MIRA
-15.25%
6M
Winner
INKT
+3.22%
MIRA
-31.51%
1Y
Winner
INKT
+62.83%
MIRA
-27.01%
5Y(CAGR)
INKT
-39.28%
MIRA
N/A
Max(CAGR)
Winner
INKT
-39.28%
MIRA
-50.63%
INKT vs MIRA - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | INKT | MIRA |
|---|---|---|
| 2026 | +6.74% | -32.89% |
| 2025 | +10.40% | +31.30% |
| 2024 | -36.06% | -4.20% |
| 2023 | -58.53% | -85.85% |
| 2022 | -45.05% | N/A |
| 2021 | -62.83% | N/A |
INKT vs MIRA Drawdown Comparison
The maximum drawdown for INKT was -97.69%, occurring on Dec 18, 2024. This drawdown has not yet recovered.
The maximum drawdown for MIRA was -92.69%, occurring on Jul 9, 2024. This drawdown has not yet recovered.
The current INKT drawdown is -94.07%. The current MIRA drawdown is -86.52%.
| Rank | INKT | MIRA |
|---|---|---|
| #1 | -97.69% Nov 11, 2021 - Dec 18, 2024 | -92.69% Aug 3, 2023 - Jul 9, 2024 |
| #2 | -12.71% Nov 2, 2021 - Nov 11, 2021 | N/A |
| #3 | -4.77% Oct 21, 2021 - Oct 27, 2021 | N/A |
| #4 | -2.50% Oct 15, 2021 - Oct 19, 2021 | N/A |
Correlation
Correlation between INKT and MIRA is 0.30 which considered as a very weak or no correlation - the stocks move independently of each other.
0.30
-101
Select Stocks to Compare
Popular: INKT vs SPYMIRA vs SPY
More Comparisons
Compare with similar stocks